Total Payments
$5,926
2024 Payments
$520.90
Companies
29
Transactions
314
Medicare Patients
13,787
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$5,911 (99.7%)
Education$15.27 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,911 | 313 | 99.7% |
| Education | $15.27 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,083 | 107 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $638.81 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $486.52 | 19 | $0 (2024) |
| Lilly USA, LLC | $376.81 | 23 | $0 (2024) |
| GENZYME CORPORATION | $297.64 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $269.85 | 17 | $0 (2022) |
| Amgen Inc. | $260.42 | 9 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $249.95 | 15 | $0 (2024) |
| Incyte Corporation | $169.46 | 10 | $0 (2024) |
| PFIZER INC. | $160.94 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $520.90 | 29 | ABBVIE INC. ($137.38) |
| 2023 | $633.31 | 28 | AbbVie Inc. ($243.38) |
| 2022 | $799.77 | 42 | ABBVIE INC. ($295.17) |
| 2021 | $474.51 | 27 | AbbVie Inc. ($237.52) |
| 2020 | $493.04 | 29 | AbbVie Inc. ($212.95) |
| 2019 | $1,103 | 67 | AbbVie, Inc. ($381.64) |
| 2018 | $965.87 | 42 | AbbVie, Inc. ($294.00) |
| 2017 | $935.53 | 50 | AbbVie, Inc. ($280.74) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Organogenesis Inc. | NOVACHOR (Medical Supply) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: WOUND CARE | ||||||
| 10/30/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Dermatology | ||||||
| 08/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.31 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ANTIBIOTIC | ||||||
| 08/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Dermatology | ||||||
| 06/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 05/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Dermatology | ||||||
| 05/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Dermatology | ||||||
| 04/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,128 | 4,657 | $2.4M | $787,210 |
| 2022 | 29 | 3,361 | 5,431 | $2.2M | $723,062 |
| 2021 | 30 | 3,704 | 5,676 | $2.1M | $779,652 |
| 2020 | 31 | 3,594 | 5,373 | $2.0M | $751,741 |
Total Patients
13,787
Total Services
21,137
Medicare Billing
$3.0M
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 548 | 680 | $996,715 | $334,962 | 33.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 275 | 418 | $370,744 | $137,838 | 37.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 146 | 186 | $255,646 | $85,628 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 466 | 646 | $124,764 | $39,757 | 31.9% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 120 | 130 | $134,015 | $26,162 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 260 | 325 | $70,699 | $22,463 | 31.8% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 48 | 56 | $47,362 | $18,033 | 38.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 166 | 192 | $46,556 | $16,573 | 35.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 78 | 84 | $77,780 | $16,466 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 162 | $44,466 | $15,018 | 33.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 286 | 373 | $53,863 | $13,056 | 24.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 68 | 93 | $33,766 | $11,763 | 34.8% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 11 | 11 | $24,070 | $9,191 | 38.2% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 12 | 12 | $20,364 | $7,711 | 37.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 96 | 175 | $19,000 | $7,245 | 38.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 207 | 894 | $12,481 | $4,489 | 36.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 31 | $12,009 | $3,877 | 32.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 75 | $9,126 | $3,165 | 34.7% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 16 | 16 | $13,532 | $2,924 | 21.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 14 | 15 | $12,984 | $2,820 | 21.7% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 13 | 13 | $12,119 | $2,490 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $6,163 | $1,903 | 30.9% |
| 13122 | Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less | Office | 2023 | 14 | 14 | $3,997 | $1,512 | 37.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 14 | 14 | $3,796 | $1,216 | 32.0% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 17 | $3,467 | $945.47 | 27.3% |
About Dr. Christopher Spock, MD
Dr. Christopher Spock, MD is a MOHS-Micrographic Surgery healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1679705677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Spock, MD has received a total of $5,926 in payments from pharmaceutical and medical device companies, with $520.90 received in 2024. These payments were reported across 314 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,911).
As a Medicare-enrolled provider, Spock has provided services to 13,787 Medicare beneficiaries, totaling 21,137 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Procedural Dermatology, Dermatology
- Location Palm Beach Gardens, FL
- Active Since 08/10/2009
- Last Updated 01/05/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1679705677
Products in Payments
- SKYRIZI (Biological) $839.75
- Humira (Biological) $766.83
- COSENTYX (Biological) $587.99
- TALTZ (Drug) $376.81
- DUPIXENT (Biological) $365.88
- DUPIXENT DUPILUMAB INJECTION (Biological) $215.75
- REMICADE (Biological) $171.08
- OPZELURA (Drug) $169.46
- Otezla (Drug) $165.60
- DUPIXENT (Drug) $154.66
- Enbrel (Biological) $133.24
- ILUMYA (Biological) $131.95
- Skyrizi (Biological) $123.06
- RINVOQ (Biological) $121.43
- EUCRISA (Drug) $87.96
- HUMIRA (Biological) $78.14
- Sotyktu (Drug) $77.29
- CIBINQO (Drug) $72.98
- TREMFYA (Drug) $72.18
- ADBRY (Biological) $71.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.